Health
Partnership to Explore Drug Delivery Approaches Labmate Online – Labmate Online
Reagents and therapeutics developer Aptamer Group has extended its existing collaboration with global biopharmaceutical company AstraZeneca to evaluate potential…
Reagents and therapeutics developer Aptamer Group has extended its existing collaboration with global biopharmaceutical company AstraZeneca to evaluate potential use of its Optimer-based strategies to target renal cells and the feasibility of developing next-generation drug delivery conjugates.
Based on oligonucleotide molecules optimers can bind specifically to a target molecule to act as an antibody alternative. Their ability to fold into distinct secondary or tertiary structures gives them high…
-
General22 hours agoByford rail extension opening marks final stage of Perth Metronet
-
General24 hours agoMango the muster cat draws attention to western Queensland’s ongoing recovery
-
General15 hours agoAustralia’s Diamonds defeat South Africa’s Proteas 65-42 in third netball Test
-
Noosa News20 hours agoSerious traffic crash, Noosa – Sunshine Coast